Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Semin Arthritis Rheum ; 66: 152422, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38461757

RESUMO

OBJECTIVE: To increase awareness and understanding of the principles of Equity, Diversity, and Inclusivity (EDI) within Outcome Measures in Rheumatology's (OMERACT) members. For this, we aimed to obtain ideas on how to promote and foster these principles within the organization and determine the diversity of the current membership in order to focus future efforts. METHODS: We held a plenary workshop session at OMERACT 2023 with roundtable discussions on barriers and solutions to increased diversity within OMERACT. We conducted an anonymous, web-based survey of members to record characteristics including population group, gender identity, education level, age, and ability. RESULTS: The workshop generated ideas to increase diversity of participants across the themes of building relationships [12 topics], materials and methods [5 topics], and conference-specific [6 topics]. Four hundred and seven people responded to the survey (25 % response rate). The majority of respondents were White (75 %), female (61 %), university-educated (94 %), Christian (42 %), spoke English at home (60 %), aged 35 to 55 years (50 %), and did not report a disability (64 %). CONCLUSION: OMERACT is committed to improving its diversity. Next steps include strategic recruitment of members to the EDI working group, drafting an EDI mission statement centering equity and inclusivity in the organization, and developing guidance for the OMERACT Handbook to help all working groups create actionable plans for promoting EDI principles.


Assuntos
Diversidade Cultural , Reumatologia , Humanos , Feminino , Masculino , Sociedades Médicas , Adulto , Pessoa de Meia-Idade , Inquéritos e Questionários
2.
J Rheumatol ; 46(8): 1021-1027, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-30770515

RESUMO

OBJECTIVE: The Outcome Measures in Rheumatology (OMERACT) Filter 2.0 framework was developed in 2014 to aid core outcome set development by describing the full universe of "measurable aspects of health conditions" from which core domains can be selected. This paper provides elaborations and updated concepts (OMERACT Filter 2.1). METHODS: At OMERACT 2018, we discussed challenges in the framework application caused by unclear or ambiguous wording and terms and incompletely developed concepts. RESULTS: The updated OMERACT Filter 2.1 framework makes benefits and harms explicit, clarifies concepts, and improves naming of various terms. CONCLUSION: We expect that the Filter 2.1 framework will improve the process of core set development.


Assuntos
Antirreumáticos/uso terapêutico , Ensaios Clínicos como Assunto , Indicadores Básicos de Saúde , Avaliação de Resultados em Cuidados de Saúde , Doenças Reumáticas/tratamento farmacológico , Humanos , Reumatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA